Search filters

List of works by James A Hay

An open source tool to infer epidemiological and immunological dynamics from serological data: Serosolver

scientific article published on 04 May 2020

Characterising antibody kinetics from multiple influenza infection and vaccination events in ferrets

scientific article published on 19 August 2019

Efficient prevalence estimation and infected sample identification with group testing for SARS-CoV-2

scientific article published on 06 May 2020

Estimating the number of undetected COVID-19 cases exported internationally from all of China

scientific article (preprint)

Life course exposures continually shape antibody profiles and risk of seroconversion to influenza

scientific article published on 23 July 2020

Long-term intrinsic cycling in human life-course antibody responses to influenza A(H3N2)

scientific article published on 27 June 2022

Near real-time surveillance of the SARS-CoV-2 epidemic with incomplete data

scientific article published on 31 March 2022

Potential inconsistencies in Zika surveillance data and our understanding of risk during pregnancy

scientific article published on 10 December 2018

Practical considerations for measuring the effective reproductive number, Rt

scientific article published on 20 June 2020

Practical considerations for measuring the effective reproductive number, Rt

scientific article published on 10 December 2020

Reconstructed influenza A/H3N2 infection histories reveal variation in incidence and antibody dynamics over the life course

scientific article published on 5 April 2024

Serosolver: an open source tool to infer epidemiological and immunological dynamics from serological data

scientific article published on 8 August 2019

Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening

scientific article published on 20 November 2020

Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance

scientific article published on 27 June 2020

Viral dynamics and duration of PCR positivity of the SARS-CoV-2 Omicron variant

Paulina is supported by:

About Paulina

Help